glucose tolerance tests (IPGTTs) (Figure 5, J and K)
The FDA reports include nausea, vomiting, diarrhea, abdominal pain, constipation, injection site reactions, and more severe outcomes including pancreatitis requiring hospitalization, gallbladder disease, severe hypoglycemia, and acute kidney injury
The column was then washed with buffer A (300 L, 2,000 g , 2 min), and 10 mM aqueous NH 4 HCO 3 containing 5% CH 3 CN (300 L, 2000 g , 2 min), before peptides were eluted from the column as 15 fractions using 300 L buffer containing an increasing concentration of CH 3 CN in 10 mM NH 4 HCO 3 (%CH 3 CN = 7.5, 10, 12.5, 15, 17.5, 20, 22.5, 25, 27.5, 30, 35, 40, 45, 50, 75) (2000 g , 2 min)
Research has looked at protective effects on a range of tissues, but human clinical data remains limited
At 24 weeks, average weight loss was: At 48 weeks, average weight loss was: The study also found that, at 48 weeks, 100% of people taking 12mg lost at least 5% of their body weight , 93% lost at least 10% , and 83% lost at least 15%
JOR Spine 3 , e1123 (2020)